Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 25, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 25, 2021Completed
Condition(s):Myelodysplastic SyndromeLast Updated:October 17, 2018Terminated
Condition(s):Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin LymphomaLast Updated:May 19, 2022Completed
Condition(s):Diffuse Large B-cell LymphomaLast Updated:January 10, 2020Completed
Condition(s):Multiple MyelomaLast Updated:June 22, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:March 25, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:February 20, 2017Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 14, 2013Completed
Condition(s):POEMS SyndromeLast Updated:July 29, 2016Completed
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:January 12, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.